[go: up one dir, main page]

TR200200438T2 - Tiazolidindion türevleri içeren farmasötik terkipler ve bu terkipleri hazırlama prosesi. - Google Patents

Tiazolidindion türevleri içeren farmasötik terkipler ve bu terkipleri hazırlama prosesi.

Info

Publication number
TR200200438T2
TR200200438T2 TR2002/00438T TR200200438T TR200200438T2 TR 200200438 T2 TR200200438 T2 TR 200200438T2 TR 2002/00438 T TR2002/00438 T TR 2002/00438T TR 200200438 T TR200200438 T TR 200200438T TR 200200438 T2 TR200200438 T2 TR 200200438T2
Authority
TR
Turkey
Prior art keywords
preparing
compositions
thiazolidinedione derivatives
pharmaceutical compositions
pharmaceutically acceptable
Prior art date
Application number
TR2002/00438T
Other languages
English (en)
Inventor
Edwin Buckingham Robin
Urquhart Michael
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9919465.6A external-priority patent/GB9919465D0/en
Priority claimed from GBGB9919842.6A external-priority patent/GB9919842D0/en
Priority claimed from GBGB9920149.3A external-priority patent/GB9920149D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200200438T2 publication Critical patent/TR200200438T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A1'in OH veya -OSO2OH; R1'in bir hidrojen atomu veya bir C1-6 alkil grubu; ve R2 ve R3'ün her birinin hidrojen oldugu veya R2 ve R3'ün birlikte bir bag oldugu formül (I) etkin toksik olmayan miktarda bir bilesigi veya bunun bir tautomerik formunun ve/veya farmasötik olarak kabul edilebilir bir tuzunun ve/veya farmasötik olarak kabul edilebilir bir solvati ile farmasötik olarak kabul edilebilir bir tasiyiciyi içeren farmasötik bir terkip.
TR2002/00438T 1999-08-17 2000-08-14 Tiazolidindion türevleri içeren farmasötik terkipler ve bu terkipleri hazırlama prosesi. TR200200438T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9919465.6A GB9919465D0 (en) 1999-08-17 1999-08-17 Novel compounds
GBGB9919842.6A GB9919842D0 (en) 1999-08-20 1999-08-20 Novel compounds
GBGB9920149.3A GB9920149D0 (en) 1999-08-25 1999-08-25 Novel compounds

Publications (1)

Publication Number Publication Date
TR200200438T2 true TR200200438T2 (tr) 2002-05-21

Family

ID=27269792

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00438T TR200200438T2 (tr) 1999-08-17 2000-08-14 Tiazolidindion türevleri içeren farmasötik terkipler ve bu terkipleri hazırlama prosesi.

Country Status (15)

Country Link
EP (1) EP1202991A1 (tr)
JP (1) JP2003507379A (tr)
KR (1) KR20020022812A (tr)
CN (1) CN1379776A (tr)
AU (1) AU7408900A (tr)
BR (1) BR0013375A (tr)
CA (1) CA2381976A1 (tr)
CZ (1) CZ2002531A3 (tr)
HU (1) HUP0202438A2 (tr)
IL (1) IL148164A0 (tr)
MX (1) MXPA02001716A (tr)
NO (1) NO20020777L (tr)
PL (1) PL353886A1 (tr)
TR (1) TR200200438T2 (tr)
WO (1) WO2001012628A1 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001260615A1 (en) * 2000-05-25 2001-12-03 Yamanouchi Pharmaceutical Co..Ltd. Human pgc-1 promoter
WO2003029251A1 (en) * 2001-09-28 2003-04-10 Biocon Limited Novel process for the synthesis of thiazolidinedione derivatives
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
KR20050068860A (ko) 2003-12-30 2005-07-05 엘지.필립스 엘시디 주식회사 듀얼 플레이트 유기전계 발광소자용 상부기판 및 그의제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
WO1995021608A1 (en) * 1994-02-10 1995-08-17 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases

Also Published As

Publication number Publication date
CN1379776A (zh) 2002-11-13
PL353886A1 (en) 2003-12-01
EP1202991A1 (en) 2002-05-08
NO20020777D0 (no) 2002-02-15
BR0013375A (pt) 2002-07-23
NO20020777L (no) 2002-02-15
HUP0202438A2 (hu) 2002-12-28
AU7408900A (en) 2001-03-13
IL148164A0 (en) 2002-09-12
MXPA02001716A (es) 2002-08-06
JP2003507379A (ja) 2003-02-25
CZ2002531A3 (cs) 2002-07-17
KR20020022812A (ko) 2002-03-27
WO2001012628A1 (en) 2001-02-22
CA2381976A1 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
HUP9802985A2 (hu) 1-(1,2-Diszubsztituált piperidinil)-4-szubsztituált piperazinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények és eljárás előállításukra
DE60003001D1 (en) Pyrimidinverbindungen
CA2257016A1 (en) Imidazolidin-4-one derivatives useful as anticancer agents
IL114690A0 (en) Indole derivatives their preparation and pharmaceutical compositions containing them
MY118904A (en) 4-oxo-1, 4-dihydro-3-quinolinecarboxamides as antiviral agents
TW358808B (en) Morpholine derivatives, preparation thereof and pharmaceutical composition containing the same
CA2340701A1 (en) Oxindole derivatives as growth hormone releasers
CA2011346A1 (en) 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
TR200103395T2 (tr) 13-metil eritromisin türevleri.
IL145759A0 (en) Amine derivatives and pharmaceutical compositions containing the same
KR960701878A (ko) 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents)
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
IL136558A0 (en) Heterocyclic cytotoxic agents
AR033300A1 (es) Compuestos de cefem
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
NO158578C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater.
TR200200438T2 (tr) Tiazolidindion türevleri içeren farmasötik terkipler ve bu terkipleri hazırlama prosesi.
PT1226122E (pt) Agonistas biciclicos da vasopressina
ATE104278T1 (de) N-substituierte alpha-mercaptoalkylaminderivate, verfahren zu ihrer herstellung und hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
TR199902019T2 (tr) Ikame edilmis tiazolidion' un hazirlanmasi için proses.
TW200500369A (en) Cephem compounds
TW350838B (en) Quinoline derivatives
NZ238033A (en) 1-indanone- or 1-tetralone-2'-amidinohydrazone derivatives and pharmaceutical compositions thereof
HUP9701479A2 (hu) Hidrolizáló csoportot tartalmazó N-benzil-azolium-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
HUP9901969A2 (hu) N-(merkapto-alkanoil)-cisztein-származékok alkalmazása ischemia kezelésére szolgáló gyógyszerkészítmények előállítására